ES2138284T3 - Substratos energeticos nutricionales reforzados enantiomericamente. - Google Patents

Substratos energeticos nutricionales reforzados enantiomericamente.

Info

Publication number
ES2138284T3
ES2138284T3 ES96200875T ES96200875T ES2138284T3 ES 2138284 T3 ES2138284 T3 ES 2138284T3 ES 96200875 T ES96200875 T ES 96200875T ES 96200875 T ES96200875 T ES 96200875T ES 2138284 T3 ES2138284 T3 ES 2138284T3
Authority
ES
Spain
Prior art keywords
nutritional
enantiomerically
chiral
energetic
strengthened
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96200875T
Other languages
English (en)
Inventor
Patrick Francis Jonas
Xavier Leverve
David Eugene Pereira
Francis Rose
W Bruce Rowe
Susan L Trimbo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter International Inc filed Critical Baxter International Inc
Application granted granted Critical
Publication of ES2138284T3 publication Critical patent/ES2138284T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/675—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids of saturated hydroxy-carboxylic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
    • A23D9/013—Other fatty acid esters, e.g. phosphatides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Food Science & Technology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

LA PRESENTE EXPOSICION SE REFIERE GENERALMENTE AL CAMPO DE LAS FORMULACIONES NUTRICIONALES ENTERALES Y PARENTERALES, EN LAS QUE SE UTILIZAN SUSTRATOS DE ENERGIA ENRIQUECIDA ENANTIOMERICAMENTE PARA PROPORCIONAR UNA DENSIDAD CALORICA ELEVADA Y UNA OSMOLARIDAD BAJA. EN PARTICULAR, GLICERILO MONOISOMERICO TRI(QUIRAL ALCANOATOS), MEZCLAS ANOMERICAS DE ALFA, ALCANOATOS BETA-DGLUCOPIRANOSILO, ESTERES DE ACIDO ALCANOICO QUIRALES MONOISOMERICOS, ESTERES DE ACIDO ALCANOICO QUIRAL ANOMERICO ADEMAS DE METODOS PARA SU PREPARACION Y SU USO EN LA NUTRICION ENTERAL O PARENTERAL PARA TRANSTORNOS METABOLICOS, TRAUMA Y MALNUTRICION.
ES96200875T 1995-04-06 1996-04-03 Substratos energeticos nutricionales reforzados enantiomericamente. Expired - Lifetime ES2138284T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/417,943 US6306828B1 (en) 1995-04-06 1995-04-06 Enantiomerically-enhanced nutritional energy substrates

Publications (1)

Publication Number Publication Date
ES2138284T3 true ES2138284T3 (es) 2000-01-01

Family

ID=23655996

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96200875T Expired - Lifetime ES2138284T3 (es) 1995-04-06 1996-04-03 Substratos energeticos nutricionales reforzados enantiomericamente.

Country Status (10)

Country Link
US (1) US6306828B1 (es)
EP (1) EP0736256B1 (es)
JP (1) JPH08283163A (es)
AT (1) ATE181485T1 (es)
AU (1) AU707531B2 (es)
CA (1) CA2173270A1 (es)
DE (1) DE69602985T2 (es)
DK (1) DK0736256T3 (es)
ES (1) ES2138284T3 (es)
GR (1) GR3031086T3 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6482853B1 (en) * 2000-07-12 2002-11-19 George A. Brooks Lactate thiolester for cardiac energy resuscitation and prevention of reperfusion injury and use as an energy supplement during exercise and recovery
NZ543201A (en) * 2003-05-01 2007-05-31 Innogene Kalbiotech Pte Ltd Lactate containing pharmaceutical composition and uses thereof
AU2004245567B2 (en) 2003-06-03 2011-06-23 Oxford University Innovation Limited Nutritional supplements and therapeutic compositions comprising (R)-3-hydroxybutyrate derivatives
EP2240017B1 (en) 2008-01-04 2019-03-13 Oxford University Innovation Limited Ketone bodies and ketone body esters as blood lipid lowering agents
US8642654B2 (en) 2009-04-16 2014-02-04 Isis Innovation Limited Hydroxybutyrate ester and medical use thereof
GB201002983D0 (en) 2010-02-22 2010-04-07 Tdeltas Ltd Nutritinal composition
JP6883384B2 (ja) 2012-11-05 2021-06-09 ザ ユナイテッド ステイツ オブ アメリカ， アズ リプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ 電離放射線による傷害から組織を防護するためのケトン体
GB201304467D0 (en) 2013-03-12 2013-04-24 Tdeltas Ltd Compound for use in protecting skin
SG11201507685UA (en) 2013-03-14 2015-10-29 Isis Innovation Process for producing (r)-3-hydroxybutyl (r)-3-hydroxybutyrate
EP3043788B1 (en) * 2013-09-13 2023-06-07 Replicon Health OY D-glyceric acid or dl-glyceric acid for use in the treatment of degeneration diseases related to aging
JP7235873B2 (ja) 2019-01-17 2023-03-08 アイオーアイ オレオ ゲーエムベーハー ヒドロキシカルボン酸のグリセリドの製造方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5195121A (en) * 1975-02-19 1976-08-20 Urogasutoronno shokakankyushuseizodaiho
JPS5334713A (en) 1976-09-09 1978-03-31 Nishikawa Yoshi Method of manufacturing 11lauroyll glucopyranose
JPS5334712A (en) 1976-09-09 1978-03-31 Nishikawa Yoshi Method of manufacturing 11stearoyll glucopyranose
US4107425A (en) * 1977-02-15 1978-08-15 The United States Of America As Represented By The Secretary Of Agriculture Preparation of 1-α- and 1-β-glucose esters by stereoselective acylation of metalated 2,3,4,6,-tetra-O-benzyl-D-glucopyranose
US4675177A (en) * 1980-10-09 1987-06-23 American Cyanamid Company Antiperspirant compositions
US4665057A (en) 1983-03-22 1987-05-12 Deanna Nelson Nutrient monoesters
US4701443A (en) 1983-03-22 1987-10-20 Baxter Travenol Laboratories, Inc. Nutrient polyesters
US4753963A (en) * 1985-09-26 1988-06-28 The Procter & Gamble Company Nutritional fat suitable for enteral and parenteral products
JPH0667833B2 (ja) * 1985-11-28 1994-08-31 雪印乳業株式会社 経腸栄養剤
GB8620896D0 (en) * 1986-08-29 1986-10-08 Unilever Plc Cosmetic composition
GB8809421D0 (en) * 1988-04-21 1988-05-25 Fordonal Sa Antacid compositions with prolonged gastric residence time
JPH0651692B2 (ja) * 1989-06-01 1994-07-06 ダイソー株式会社 光学活性化合物
JPH0383950A (ja) * 1989-08-28 1991-04-09 Kanegafuchi Chem Ind Co Ltd グリセリド誘導体およびその製造法
EP0465689B1 (fr) 1990-07-09 1994-02-02 Societe Des Produits Nestle S.A. Composition alimentaire hypocalorique
US5256697A (en) 1992-04-16 1993-10-26 Abbott Laboratories Method of administering pyruvate and methods of synthesizing pyruvate precursors
US5308832A (en) 1992-07-27 1994-05-03 Abbott Laboratories Nutritional product for persons having a neurological injury
US5263260A (en) 1992-08-03 1993-11-23 Smith Lee R Tile leveler and method
ATE175444T1 (de) * 1992-10-29 1999-01-15 Loders Croklaan Bv Enzymatisches triglycerid-umsetzverfahren
WO1995009144A1 (en) * 1993-09-30 1995-04-06 Eastman Chemical Company Nutritive water soluble glycerol esters of hydroxy butyric acid

Also Published As

Publication number Publication date
EP0736256A1 (en) 1996-10-09
US6306828B1 (en) 2001-10-23
EP0736256B1 (en) 1999-06-23
JPH08283163A (ja) 1996-10-29
AU5045696A (en) 1996-10-17
DK0736256T3 (da) 1999-11-22
CA2173270A1 (en) 1996-10-07
AU707531B2 (en) 1999-07-15
GR3031086T3 (en) 1999-12-31
DE69602985D1 (de) 1999-07-29
ATE181485T1 (de) 1999-07-15
DE69602985T2 (de) 2000-02-17

Similar Documents

Publication Publication Date Title
DK0736256T3 (da) Enantiomert-berigede ernæringsmæssige energisubstrater
DK0515460T4 (da) Docosahexaensyre, fremgangsmåder til fremstilling deraf og forbindelser indeholdende samme
AU586892B2 (en) Pharmaceutical and dietary composition
MY112705A (en) Tryglycerides
ATE148920T1 (de) Verfahren zur enzymatischen herstellung von alpha-sialylierten oligosaccharid-glykosiden
EP0454102A3 (en) Essential fatty acid compositions
CA2244608A1 (en) Nutritional product with high fat, low carbohydrate and amino acid imbalance
DE602005017707D1 (de) Verfahren zur Herstellung von Dipeptiden oder Dipeptidderivaten.
IL106976A0 (en) Nutrition for persons undergoing radiation therapy and/or chemotherapy
DK0754001T3 (da) Næringsmiddelprodukt til behandling af colitis ulcerosa og anvendelse deraf
GB8812653D0 (en) Pharmaceutical composition based on high concentration esters of docosahexaenoic acid
AU652785B2 (en) Nutrition
NO984859L (no) Additiv for anvendelse i et energitilskudd, anvendelse av et proteinhydrolysat for fremstilling av energitilskudd inneholdende et slikt additiv
AU2002305011A1 (en) Enzyme treated maple syrup, shelf stable, pure maple based products, and blended products
UA27817C2 (uk) Спосіб біокаталітичного одержання одного з енантіомерів хіральної 2-арилалканової кислоти
ATE129233T1 (de) Dicarbonsäure-derivate von 6-12 kohlenstoffatomen sowie anwendung dieser derivate sowie der freien dicarbonsäuren zur herstellung von arzneimitteln zur enteralen und parenteralen ernährung.
EP0400499A3 (de) Neue Acylaminosäurederivate enthaltende Arzneimittel und Diätetika
JPS6442414A (en) Skin-beautifying cosmetic
EP0328420A3 (en) Gangliosides containing de-n-acetyl-sialic acid and their applications as modifiers of cell physiology
Sandanov et al. Characteristics of central metabolism in coryneform bacteria
JPS6474995A (en) Production of prostaglandin
JPS5414583A (en) Cultivation of yeast containing small amount of odd c-number fatty acid
Van Buren Nutrition and Immunology
Van Buren Immunonutrition
JPS5362895A (en) Preparation of 5'-inosinic acid by fermentation

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 736256

Country of ref document: ES